What’s so influential and beneficial that it could bring much of the top medtech OEMs under the same roof?
The answer is Medaccred, an industry managed, critical process supply chain oversight program, that reduces risk to patient safety, assures quality products and verified compliance with requirements.
During IME West, the organization announced the launch of a new contract manufacturer program. The initiative was established to help enable better oversite of contract manufacturers sub-tier suppliers.
The new program was developed by medical device company MedAccred Subscribers Bausch Health, Baxter, BD, Boston Scientific, Edwards Lifesciences, Johnson & Johnson, Medtronic, Philips Healthcare, Roche Diagnostics, and Stryker.
The organization said that the Contract Manufacturer Subscriber program will build upon the current MedAccred program and provide oversight of critical manufacturing processes conducted by subject matter expert auditors.
“The creation of a new MedAccred Contract Manufacturer Subscriber program is an exciting development that is going to help contract manufacturers within the medical technology industry develop greater oversight and control across their supply chains,” said Dannette Crooms, Vice President, Global Supplier Quality, Edwards Lifesciences. “This innovation will go a long way towards supporting quality and patient safety across the medical industry.”
Connie Conboy, Director, MedAccred, said “Contract Manufacturers and their sub-tier suppliers are responsible for over 70% of all medical device manufacturing. The complexity of the supply chain through its many tiers poses a risk to product quality and patient safety which is what the new Contract Manufacturer Subscriber Program seeks to address.”